CCEL Insider Trading

Insider Ownership Percentage: 36.86%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Cryo-Cell International Insider Trading History Chart

This chart shows the insider buying and selling history at Cryo-Cell International by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100k$0$100kTotal Insider BuyingTotal Insider Selling

Cryo-Cell International Share Price & Price History

Current Price: $6.45
Price Change: Price Increase of +0.12 (1.90%)
As of 04/4/2025 05:10 PM ET

This chart shows the closing price history over time for CCEL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$6.45Closing price on 04/05/25:

Cryo-Cell International Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Cryo-Cell International (NYSEAMERICAN:CCEL)

10.44% of Cryo-Cell International stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CCEL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$815kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M-$1M$0$1M$2MTotal InflowsTotal Outflows
Cryo-Cell International logo
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Read More on Cryo-Cell International

Today's Range

Now: $6.45
Low: $6.20
High: $6.50

50 Day Range

MA: N/A

52 Week Range

Now: $6.45
Low: $5.75
High: $9.50

Volume

12,423 shs

Average Volume

12,398 shs

Market Capitalization

$51.99 million

P/E Ratio

N/A

Dividend Yield

12.42%

Beta

0.53